Virendra Kumar
B2 novartis
February 12, 2014 Life Sciences Enforcement Year in Review: Examining Hot Button Areas for FDA & Related Government Enforcement Peter Spivack, Hogan Lovells.
OFF-LABEL MARKETING & THE FALSE CLAIMS ACT THOMAS M. GREENE Greene & Hoffman November 17, 2004.
W ORKING WITH P HARMA S PONSORS IN R ESEARCH Becky Hubbell, PharmD, MBA Sr Ex Dir, Clinical Research Operations.
Healthcare Fraud David Burris Senior Director Alvarez & Marsal Dispute Analysis & Forensic Services Washington DC/Tampa FL 21st Annual ECI Conference.
1 Innovative Models of Compliance Education: The Intellinex™ Case Study (August 24, 2006) Jeffrey L. Lenow, MD, JD, FAAFP Associate Professor, Department.
KEY ENFORCEMENT ISSUES - The Government's Perspective Kathleen Meriwether Assistant United States Attorney Eastern District of Pennsylvania UNITED STATES.
